API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biopharmadive.com/news/cerevel-parkinsons-tavapadon-study-results-abbvie/713566/
https://www.globenewswire.com/news-release/2024/04/18/2865216/0/en/Cerevel-Therapeutics-Announces-Positive-Topline-Results-for-Tavapadon-in-Phase-3-Adjunctive-Trial-for-People-Living-with-Parkinson-s-Disease.html
https://endpts.com/cerevel-blames-covid-for-delayed-neuroscience-studies-says-president-is-leaving/
https://www.biospace.com/article/releases/cerevel-therapeutics-announces-first-patients-dosed-in-all-phase-3-trials-of-tavapadon-for-the-treatment-of-parkinson-s-disease/